Find a Commonwealth Resource
Inebilizumab
HealthData.Gov
Updated Mar 24, 2026
About this dataset
UPLIZNA (inebilizumab) is a prescription monoclonal antibody that targets CD19 on immune cells. It's administered intravenously for certain autoimmune conditions. Manufactured by Viela Bio and Horizon Therapeutics, it's available as a 10 mg/mL solution in single-dose vials. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Inebilizumab
Access the FDA dataset for Inebilizumab — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025